Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Genmab reported DKK12.29B in Cash and Equivalent for its fiscal quarter ending in March of 2023.

Cash And Equivalent Change
Agios Pharmaceuticals AGIO:US USD 104.14M 35.12M
Almirall SA ALM:SM EUR 248.38M 24.12M
Amarin AMRN:US USD 191.41M 26.25M
Amgen AMGN:US USD 31.56B 22.26B
Artemis Alpha ATS:LN GBP 978K 1.41M
AstraZeneca AZN:LN USD 6.23B 66M
Bayer BAYN:GR EUR 4.85B 317M
BioMarin Pharmaceutical BMRN:US USD 580.07M 144.46M
Bluebird Bio BLUE:US USD 239.04M 126.04M
Exelixis EXEL:US USD 540.6M 39.4M
Galapagos GLPG:NA EUR 124.14M 383.98M
Genmab GEN:DC DKK 12.29B 2.4B
GlaxoSmithKline GSK:LN GBP 2.89B 833M
GN Store Nord GN:DC DKK 676M 314M
Hikma Pharmaceutical HIK:LN USD 1000K 22M
Immunogen IMGN:US USD 201.25M 73.89M
Insmed INSM:US USD 968.91M 105.13M
Lonza Group LONN:SW CHF 1.34B 187M
Merck MRK:GR EUR 1.58B 270M
Novartis NOVN:VX USD 12B 4.48B
Regeneron Pharmaceuticals REGN:US USD 3.92B 810.4M
Roche Holding ROG:VX CHF 4.99B 676M
Seattle Genetics SGEN:US USD 335.85M 15.91M